Document is current
Any future updates will be listed below
-
Authors
Lambert, Samuel A. https://orcid.org/0000-0001-8222-008X
Gil, Laurent https://orcid.org/0000-0002-9475-4502
Jupp, Simon
Ritchie, Scott C. https://orcid.org/0000-0002-8454-9548
Xu, Yu https://orcid.org/0000-0002-7304-5045
Buniello, Annalisa
McMahon, Aoife https://orcid.org/0000-0003-0978-0309
Abraham, Gad
Chapman, Michael https://orcid.org/0000-0002-4582-6303
Parkinson, Helen
Danesh, John
MacArthur, Jacqueline A. L. https://orcid.org/0000-0002-3550-9769
Inouye, Michael https://orcid.org/0000-0001-9413-6520
-
Funding
Funding for this research was provided by:
Baker IDI Heart and Diabetes Institute (Munz Chair)
Baker IDI Heart and Diabetes Institute (CBSGI)
Baker IDI Heart and Diabetes Institute (CBSGI)
Baker IDI Heart and Diabetes Institute (CBSGI)
Baker IDI Heart and Diabetes Institute (CBSGI)
Gouvernement du Canada | Canadian Institutes of Health Research (MFE-171279)
Health Data Research UK
European Bioinformatics Institute
British Heart Foundation (Professorship)
- License Information
-
More Information
Article History
First Online: 10 March 2021
Competing interests
: J.D. is part of the International Cardiovascular and Metabolic Advisory Board for Novartis (since 2010); the Steering Committee of UK Biobank (since 2011); the MRC International Advisory Group (ING), London (since 2013); the MRC High Throughput Science Omics Panel, London (since 2013); the Scientific Advisory Committee for Sanofi (since 2013); the International Cardiovascular and Metabolism Research and Development Portfolio Committee for Novartis; and the Astra Zeneca Genomics Advisory Board (2018).
